Compare · EW vs MTRN
EW vs MTRN
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Materion Corporation (MTRN): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while MTRN operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $52.38B, about 10.8x MTRN ($4.84B).
- MTRN has been more active in the news (8 items in the past 4 weeks vs 3 for EW).
- EW has more recent analyst coverage (25 ratings vs 10 for MTRN).
- Company
- Edwards Lifesciences Corporation
- Materion Corporation
- Price
- -
- -
- Market cap
- $52.38B
- $4.84B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 3
- 8
- Recent ratings
- 25
- 10
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Materion Corporation
Materion Corporation manufactures and sells advanced engineered materials used in semiconductor, industrial, aerospace and defense, automotive, energy, consumer electronics, and telecom and data center markets in the United States, Asia, Europe, and internationally. It operates through Performance Alloys and Composites, Advanced Materials, and Precision Optics segments. The Performance Alloys and Composites segment provides copper and nickel products in plate, rod, bar, tube, strip, wire product forms, as well as other customized shapes; precision strip products; beryllium hydroxide; and beryllium products, such as beryllium composites, ceramics, and engineered clad and plated metal systems, as well as aluminum silicon carbide metal matrix. This segment also produces strip metal products with clad inlay and overlay metals consisting of precious and base metal electroplated systems, electron beam welded systems, contour profiled systems, and solder-coated metal systems. The Advanced Materials segment provides advanced chemicals, microelectronics packaging, precious and non-precious metals, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms, high temperature braze materials, and ultra-pure wires. The Precision Optics segment produces sputter-coated precision thin film coatings and optical filter materials. It distributes its products through company-owned facilities, and independent distributors and agents. The company was formerly known as Brush Engineered Materials Inc. and changed its name to Materion Corporation in 2011. Materion Corporation was incorporated in 1931 and is headquartered in Mayfield Heights, Ohio.
Latest EW
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,967 worth of shares (619 units at $92.03) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form S-8 filed by Edwards Lifesciences Corporation
- SEC Form 10-Q filed by Edwards Lifesciences Corporation
- CVP, JAPAC Markowitz Wayne sold $12,588 worth of shares (146 units at $86.03), decreasing direct ownership by 0.67% to 21,534 units (SEC Form 4)
- CVP, JAPAC Markowitz Wayne exercised 9,628 shares at a strike of $74.02 and sold $818,958 worth of shares (9,628 units at $85.06) (SEC Form 4)
- UBS initiated coverage on Edwards Lifesciences with a new price target
- CEO Zovighian Bernard J gifted 320 shares, received a gift of 320 shares and sold $245,134 worth of shares (2,921 units at $83.93), decreasing direct ownership by 0.32% to 98,845 units (SEC Form 4)
- Edwards Lifesciences upgraded by Leerink Partners with a new price target
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports Second Quarter Results
Latest MTRN
- Director Liggett Emily M gifted 1,609 shares, decreasing direct ownership by 28% to 4,173 units (SEC Form 4)
- Director Toth Robert B gifted 28,832 shares and received a gift of 28,832 shares, closing all direct ownership in the company (SEC Form 4)
- Vice President, Finance & CFO Chadwick Shelly Marie exercised 4,972 shares at a strike of $114.52, covered exercise/tax liability with 3,267 shares and sold $499,565 worth of shares (1,705 units at $293.00) (SEC Form 4)
- Director Solomon Darlene J. S. sold $1,082,690 worth of shares (3,705 units at $292.22), decreasing direct ownership by 12% to 26,718 units (SEC Form 4)
- President and CEO Vijayvargiya Jugal K. exercised 24,594 shares at a strike of $68.82, covered exercise/tax liability with 13,146 shares and sold $7,096,839 worth of shares (24,336 units at $291.62), decreasing direct ownership by 10% to 116,699 units (SEC Form 4)
- SEC Form 10-Q filed by Materion Corporation
- Materion Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Materion Corporation Reports Record Second-Quarter 2026 Financial Results and Raises Full-Year Outlook
- Materion Corporation Declares Quarterly Cash Dividend
- Materion Corporation to Announce Second Quarter 2026 Financial Results on August 5